I noticed the FDA put the approval of Plasma therapy for
I noticed the FDA put the approval of Plasma therapy for Covid on hold today due to "weak data from the study". The other two headlines below show the complete failure in Covid trials by IL-6 drugs. These drugs are from some very heavy hitters like Roche, Sanofi and Regeneron. Meanwhile, Leronlimab has achieved what Dr Fauci has requested since the onset of Covid. That is to provide statistically significant data in a 2:1, double blinded FDA trial. In addition, Leronlimab has outstanding EIND data and a safety profile that is second to none. You really have wonder why this molecule gets no traction.
F.D.A.’s Emergency Approval of Blood Plasma Is Now on Hold
Government health leaders including Dr. Francis S. Collins and Dr. Anthony S. Fauci urged caution last week, citing weak data from the country’s largest plasma study.
Roche declares a Ph3 failure for Covid-19 as the IL-6 repurposing theory bites the dust
John Carroll
Editor & Founder
Another big IL-6 drug has failed to move the needle for Covid-19 patients, leaving that particular field of repurposed drug R&D on the ropes for the pandemic.
IL-6 hypothesis looking shaky as Kevzara fails COVID-19 trial
Hopes that already-approved drugs targeting IL-6 could be repurposed to treat COVID-19 have been undermined by disappointing results from the first large-scale trial of Sanofi and Regeneron’s Kevzara.July 3, 2020
3
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Pinch of Pragmatism in Teciem's Boardroom Teciem's board just got a shot of reality with the appointment of Alla Whitston from MUFG Americas. Now, how often can one say a board director actually knows what it’s like on the other side of the vendor relationship? Not often, my friends. But here you’ve got Whitston, who's seen all the tech tribulations banks face from...
Continue Reading
Redefining Eligibility for Inclusive Progress Picture this: the landscape of educational support shifting towards inclusivity. The Hispanic Scholarship Fund (HSF), long a champion for Hispanic educational advancement, is taking a bold step by opening its doors wider. From January 2027, the HSF Scholar Program will embrace students of all backgrounds, a massive leap away...
Continue Reading
Biozen's Bold Leap in Blood Pressure Measurement You think blood pressure measurement, you think inconvenience—right? Not so fast. Biozen's got something up their sleeve that's shifting the game. At the latest American Heart Association's Scientific Sessions in Chicago, Biozen's bigwigs whipped out their new tech: the BP2000. This isn't just any update; it's a 40% cut...
Continue Reading
New Talent Joins a Leading Family Law Firm Some folks think of family law as just another branch of the legal world, but let's be real—it's where emotions run high and stakes can catch you off guard like a sudden market downturn. So, when McKinley Irvin, one of the Pacific Northwest’s top family law outfits, brings someone new aboard, that’s worth putting under the...
Continue Reading
NMIXX Takes K-Pop To Cinemas Worldwide When it comes to turning audacious ideas into reality, CJ 4DPLEX is making noise by blasting NMIXX's concert right onto the big screens across the globe. We're not just talking about a regular cinema trip here—no popcorn flick nonsense. On November 29, get ready for a ride with the NMIXX 1ST WORLD TOUR?EPISODE 1: ZERO...
Continue Reading
Clarity Amid Chaos: Handling a Crash in Abilene Let me tell you, if your day starts with a car wreck, every second post-crash counts more than you think. Attorney Chaile Allen out of Abilene's laying down the law on how to protect yourself—because that wreck scene ain't just about bent fenders and bruised egos. It's about getting your ducks in a row for any potential...
Continue Reading
Diving Headfirst into the Hydration Trenches It seems Stephen and Allison Ellsworth can't sit still for long. They've come out swinging yet again, this time unveiling their new hydration brand, 'jetty', poised to stir up the $13 billion electrolyte drink industry. These folks aren’t just dipping their toes in either—they're plunging right in with a product line...
Continue Reading
End-to-End AI: Revolution at TIER IV Well, folks, TIER IV is shaking things up in the world of autonomous driving. They've just rolled out a bunch of end-to-end (E2E) AI models under the open-source banner of Autoware. Each model is designed to adapt to different map and sensor setups. You know, it’s like they're handing the keys of customization to developers—whether...
Continue Reading
A Milestone in Dementia Care Excellence Angels on Call Homecare has done what no other U.S. homecare provider seems to have managed—nab recognition from the Alzheimer's Association Curriculum Review while also holding the Purple Flag accreditation. That's a combo meal of accolades in the world of dementia care, and it speaks volumes about their commitment to top-notch...
Continue Reading
E-Bike Enthusiasm Meets Dangerous Fire Risks Imagine this: your sleek new e-bike, your pride and joy, becomes a ticking time bomb. That's the reality facing more folks than we'd like these days, as e-bike battery fires surge across the globe. Amidst the holiday hustle, Li-Fire hits the scene with a lifeline—a free replacement program for their E-bike Lithium Fire Cover....
Continue Reading
MoreBetter's Therapy Co-Investment: A Big Bet on Patient Data">
Continue Reading